SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

which is a compound made of GLP1 too, was categorized by the FDA as a drug in shortage. The drug was then taken off the list and it seems that decision is being reversed. Obviously, this has huge ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

While the diabetes business should continue delivering solid growth, our core investment thesis is centered around the company entering a big profit cycle driven by its GLP1 drugs, namely its ...

The Food and Drug Administration (FDA ... "It’s possible that so many patients presently taking compounded GLP1s will be ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy ... for validating Amgen’s unique strategy of combining a GLP1-R agonist with a GIPR antagonist—potentially positioning MariTide ...

Obesity is on the rise and with it, a class of fat-fighting drugs have taken the world by ... for the currently marketed product containing GLP1s in different geographies at different times ...

Our next 'Walk with a Doc' will be this Saturday, Nov. 16, 2024 at 11 a.m.Meeting Place: Burien Town Square Park, 480 SW ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia– but for patients, on gGLP-1's there may still be gastric juices, in the stomach, since the ...